Cyclin-dependent kinase inhibitor 2A (CDKN2A) was the first high-penetrance melanoma gene identified and encodes two distinct proteins (p16 and p14ARF), both acting in cell cycle regulation [7]. The gene discussed is CDKN2A; the disease is melanoma.